Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1)
- PMID: 17289224
- DOI: 10.1016/j.vaccine.2007.01.057
Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1)
Abstract
Cysteine proteinases released by Fasciola hepatica play a key role in parasite feeding, migration through host tissues and in immune evasion. Hence, a recombinant cysteine proteinase (CPFhW) expressed as inclusion bodies in Escherichia coli was used for enteral vaccination of rats against fasciolosis. We managed to activate this proteinase and found it to have cathepsin L1-like substrate preference. Enteral vaccination of rats induced a 78-80% protection against challenge with fluke metacercariae (mc). The immunised rats showed clear immunological response. The challenge with mc caused a remarkable infiltration of eosinophils into the peritoneal cavity of both the vaccinated rats and challenge control rats. However, CD8+ and CD4+ lymphocytes appeared in significantly higher numbers in the peritoneal fluid of vaccinated rats than in controls.
Similar articles
-
Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.Vet Parasitol. 2007 Jun 20;147(1-2):77-88. doi: 10.1016/j.vetpar.2007.03.023. Epub 2007 May 3. Vet Parasitol. 2007. PMID: 17481823 Clinical Trial.
-
Fasciola hepatica procathepsin L3 protein expressed by a baculovirus recombinant can partly protect rats against fasciolosis.Vaccine. 2005 Apr 27;23(23):2987-93. doi: 10.1016/j.vaccine.2004.12.007. Vaccine. 2005. PMID: 15811644
-
Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.PLoS Negl Trop Dis. 2017 Mar 23;11(3):e0005451. doi: 10.1371/journal.pntd.0005451. eCollection 2017 Mar. PLoS Negl Trop Dis. 2017. PMID: 28333957 Free PMC article.
-
Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.Res Vet Sci. 2001 Feb;70(1):83-6. doi: 10.1053/rvsc.2000.0425. Res Vet Sci. 2001. PMID: 11170858 Review.
-
Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.Int J Parasitol. 2003 Sep 30;33(11):1173-81. doi: 10.1016/s0020-7519(03)00171-1. Int J Parasitol. 2003. PMID: 13678633 Review.
Cited by
-
Effect of lipopolysaccharide (LPS) from Ochrobactrum intermedium on sheep experimentally infected with Fasciola hepatica.Parasitol Res. 2013 Aug;112(8):2913-23. doi: 10.1007/s00436-013-3463-7. Epub 2013 Jun 6. Parasitol Res. 2013. PMID: 23739808 Clinical Trial.
-
Attacking the Intruder at the Gate: Prospects of Mucosal Anti SARS-CoV-2 Vaccines.Pathogens. 2022 Jan 19;11(2):117. doi: 10.3390/pathogens11020117. Pathogens. 2022. PMID: 35215061 Free PMC article. Review.
-
High relatedness of bioinformatic data and realistic experimental works on the potentials of Fasciola hepatica and F. gigantica cathepsin L1 as a diagnostic and vaccine antigen.Front Public Health. 2022 Dec 7;10:1054502. doi: 10.3389/fpubh.2022.1054502. eCollection 2022. Front Public Health. 2022. PMID: 36568750 Free PMC article.
-
Transcriptome Analysis Reveals the Molecular Response to Salinity Challenge in Larvae of the Giant Freshwater Prawn Macrobrachium rosenbergii.Front Physiol. 2022 Apr 29;13:885035. doi: 10.3389/fphys.2022.885035. eCollection 2022. Front Physiol. 2022. PMID: 35574435 Free PMC article.
-
Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2.Mol Biol Rep. 2018 Oct;45(5):1551-1556. doi: 10.1007/s11033-018-4251-3. Epub 2018 Jul 21. Mol Biol Rep. 2018. PMID: 30032380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials